https://www.nature.com/articles/d41586-023-03797-7
NEWS
07 December 2023
Landmark approval of the first CRISPR therapy paves the way for treatments based on more efficient and more precise genome editors.
By
Heidi Ledford
More versatile genome editors are supplanting the CRISPR-Cas9...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.